TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 98,548 | 94,342 | 96,153 |
Earnings before taxes | 3,000 | 2,263 | 3,956 |
Total assets | 47,668 | 50,870 | 47,090 |
Current assets | 47,638 | 46,645 | 42,576 |
Current liabilities | 27,971 | 31,868 | 25,529 |
Equity capital | 19,295 | 17,103 | 21,411 |
- share capital | 538 | 538 | 535 |
Employees (average) | 150 | 150 | 150 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 40.5% | 33.6% | 45.5% |
Turnover per employee | 657 | 629 | 641 |
Profit as a percentage of turnover | 3.0% | 2.4% | 4.1% |
Return on assets (ROA) | |||
Current ratio | 170.3% | 146.4% | 166.8% |
Return on equity (ROE) | 15.5% | 13.2% | 18.5% |
Change turnover | 4,166 | -2,203 | -12,038 |
Change turnover % | 4% | -2% | -11% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.